Sitero Revenue and Competitors
Employee Data
- Sitero has 349 Employees.
- Sitero grew their employee count by 46% last year.
Sitero's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Product Owner | Reveal Email/Phone |
2 | VP, Clinical Technologies | Reveal Email/Phone |
3 | VP- Head Global Sales | Reveal Email/Phone |
4 | Manager, PSRM | Reveal Email/Phone |
5 | Software Testing Analyst 3 | Reveal Email/Phone |
6 | Duals Market Lead | Reveal Email/Phone |
7 | Clinical Payments Specialist | Reveal Email/Phone |
8 | Java Software Developer | Reveal Email/Phone |
9 | Software Test Analyst III | Reveal Email/Phone |
10 | Senior Clinical Systems Lead | Reveal Email/Phone |
Sitero Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 349 | 46% | N/A | N/A |
#2 | N/A | 25 | 67% | N/A | N/A |
#3 | $7.5M | 109 | -4% | N/A | N/A |
#4 | N/A | 69 | 25% | N/A | N/A |
#5 | N/A | 171 | 43% | N/A | N/A |
#6 | N/A | 43 | -16% | N/A | N/A |
#7 | N/A | 46 | 44% | N/A | N/A |
#8 | N/A | 5 | 150% | N/A | N/A |
#9 | N/A | 38 | 58% | N/A | N/A |
#10 | N/A | 16 | 7% | N/A | N/A |
What Is Sitero?
Sitero is a next-generation, site-focused clinical research organization (CRO) for life sciences and institutional research organizations that helps get treatments to market safer and faster through tech-forward services that streamline research. Accelerate your clinical trial, drive compliance and safety, and unlock innovation with access to powerful technology and world-class services. Sitero combines the expertise of a tenured team with a nimble, innovative approach to clinical research. Sitero has offices in the U.S., U.K., and India.
keywords:N/AN/A
Total Funding
349
Number of Employees
N/A
Revenue (est)
46%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $52.8M | 352 | 15% | N/A |
#2 | $191.9M | 380 | 2% | $217M |
#3 | $123.5M | 395 | 1% | N/A |
#4 | $72.3M | 399 | N/A | N/A |
#5 | $80.8M | 407 | 4% | N/A |